TIAA Trust National Association Increases Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

TIAA Trust National Association boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 33.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,154 shares of the financial services provider’s stock after buying an additional 787 shares during the period. TIAA Trust National Association’s holdings in iShares Biotechnology ETF were worth $417,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Main Management ETF Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 2.5% during the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after buying an additional 14,535 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth $55,010,000. Gray Foundation raised its position in iShares Biotechnology ETF by 25.2% in the fourth quarter. Gray Foundation now owns 164,872 shares of the financial services provider’s stock valued at $21,798,000 after purchasing an additional 33,179 shares during the period. Aprio Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at $18,476,000. Finally, Avalon Trust Co grew its holdings in shares of iShares Biotechnology ETF by 0.7% during the 4th quarter. Avalon Trust Co now owns 127,893 shares of the financial services provider’s stock worth $16,909,000 after purchasing an additional 935 shares during the period. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 1.0 %

Shares of NASDAQ:IBB opened at $130.29 on Friday. The company has a market capitalization of $6.16 billion, a price-to-earnings ratio of 27.83 and a beta of 0.84. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The business has a 50-day moving average price of $136.16 and a 200 day moving average price of $138.96.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were given a dividend of $0.1212 per share. The ex-dividend date was Tuesday, March 18th. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.